http://www.cuminggillespie.com

Cuming, Gillespie & Raymaker continue to proceed with the Canadian National Class Action with respect to the Vioxx claims.

The Vioxx claims within the U.S. only have been resolved for the sum of $4,850,000.00 dollars pursuant to an agreement between Merck & Co. Inc and a six member negotiating committee on behalf of all U.S. Plaintiffs. The details of the U.S. settlement are available online at www.officialvioxxsettlement.com.

The claim has not resolved and will be proceeding to a certification hearing in 2008.

An amended order from the court on the HMS Financial case has been posted.

The Instaloans National Class Action claim is now completed. All individuals who have submitted claims have either received their compensation or have been denied their claim pursuant to the review of the Claims Administrator under the guidelines set out by the Ontario Superior Court of Justice.

No new claims can be processed through the Class Action.

All individuals who have or may have a perspective claim are free to proceed as against the Defendants exclusive of the Class Action in any jurisdiction in Canada.

Cuming, Gillespie & Raymaker will not be acting on behalf of any individual claimants in this matter.